Brain Health
22 articles on Brain Health, researched and written by the Shotlee Editorial Team from primary sources.
GLP-1s and Alzheimer's: Hope, Hype, and the Science of Prevention
GLP-1 receptor agonists are showing promise for brain health by reducing inflammation, but experts caution that using these powerful medications solely for dementia prevention is premature, especially given mixed clinical trial results.
6 min read
Beyond Appetite: How GLP-1 Drugs May Be Rewiring the Human Brain
GLP-1 receptor agonists, initially celebrated for revolutionizing diabetes and weight management, are now at the center of an unplanned, massive neuroscience experiment. Emerging data suggests these powerful medications are doing more than just regulating metabolism; they appear to be structurally and functionally altering key brain systems.
7 min read
Beyond Ozempic: How MCT Oil Offers Natural Weight & Wellness Support
Discover the natural power of MCT oil, a coconut derivative that's gaining attention for its potential to aid weight loss, boost energy, and enhance mental clarity. Learn how it works and if it's the right choice for you.
9 min read
Beyond Weight Loss: Surprising Health Benefits of GLP-1 Drugs
While widely recognized for their effectiveness in weight management, GLP-1 receptor agonists are revealing a spectrum of profound health benefits. Discover how these groundbreaking medications are impacting cardiovascular health, kidney function, liver disease, and even potentially neurodegenerative conditions.
7 min read
Mediterranean Diet's Cellular Secret: Unlocking Anti-Aging Proteins
A groundbreaking study reveals that the Mediterranean diet may boost cellular health by activating specific mitochondrial microproteins, offering a new perspective on its profound anti-aging benefits.
7 min read
Understanding Insulin Resistance: Beyond Blood Sugar
Insulin resistance is a critical metabolic condition affecting blood sugar regulation and potentially impacting brain function. This comprehensive guide delves into its causes, symptoms, and the vital role of lifestyle interventions.
8 min read
Eli Lilly 150 Years: AI, GLP-1 Advances & Future of Weight Loss
Eli Lilly celebrates 150 years with a focus on AI-driven manufacturing, new GLP-1 oral therapies, and expanded neuroscience research, signaling a major shift in pharmaceutical innovation.
8 min read
Should You Take GLP-1 Drugs for Longevity?
A quote from The Economist's Style Guide warns against calling anything a panacea—yet GLP-1 drugs for type 2 diabetes and obesity are now eyed by healthy individuals for longevity. Is their time as a miracle cure finally here? This guide weighs the excitement against expert caution and real-world considerations.
4 min read
Sex-Specific GLP-1 Brain Atlas Reveals Drug Impact Differences
A new peer-reviewed study from Mount Sinai researchers has created the first sex-specific atlas of GLP-1 expression in the mouse brain, revealing dramatic differences between males and females. These insights into drugs like semaglutide and liraglutide could reshape treatments for obesity, diabetes, and even psychiatric disorders. Key hindbrain and olfactory bulb variations highlight why GLP-1 effects on appetite and weight loss differ by sex.
5 min read
This Week in Science: Ozempic's Joint Benefits, Superagers Secrets & More
This week's science news uncovers surprising benefits of Ozempic for joint health beyond weight loss, reveals why superagers stay sharp with more new brain neurons, and highlights food quality over diet type for heart protection. From cholesterol-lowering oatmeal diets to a universal nasal vaccine, these findings offer fresh hope for metabolic and cognitive health.
5 min read
RFK Jr. Plans to Unban 14 FDA-Banned Peptides, Tells Joe Rogan
RFK Jr. revealed on the Joe Rogan Experience his intent to lift FDA restrictions on 14 banned peptides from compounding pharmacies. This reversal addresses the late 2023 Category 2 list ban amid safety concerns and black market shifts. Patients and wellness advocates await formal decisions in coming weeks.
5 min read
SNAC in Ozempic and Wegovy Tablets Raises Gut Health Questions, Study Finds
New research uncovers potential effects of SNAC—the hidden ingredient enabling Ozempic and Wegovy tablets—on gut health. In a 21-day animal study, repeated exposure led to shifts in harmful gut bacteria, elevated inflammation, and depleted cognitive proteins. While not proving harm in humans, findings urge caution as oral semaglutide use surges.
6 min read
Tanmay Bhat on GLP-1 Drugs Failing Appetite Suppression & Genetic Report
Comedian Tanmay Bhat recently opened up about his disappointing experience with GLP-1 medications, reporting zero appetite suppression despite using them for weight management. He attributes this to a BDNF gene variant affecting satiety signaling, sparking discussions on genetic factors in treatment response. While many see benefits from drugs like semaglutide and tirzepatide, Bhat's story highlights why results vary.
5 min read
Study Flags Gut Risks from SNAC in Oral Weight-Loss Pills
A groundbreaking study from Adelaide University is raising questions about SNAC, the ingredient making oral weight-loss drugs like semaglutide tablets viable. In a 21-day animal model, repeated SNAC exposure linked to lower beneficial gut bacteria, reduced protective compounds, and elevated inflammation markers. As tablet versions gain popularity, experts call for more research on this component's full impact.
6 min read
Semax: Potential of a Synthetic Peptide in Neuroscience Research
Semax, a synthetic heptapeptide derived from ACTH research, is capturing interest for its neuroactive properties without endocrine effects. Ongoing studies highlight its roles in neuroplasticity, stress resilience, and cognitive function. This guide delves into the science behind its multifaceted research potential.
5 min read
Brain Insulin Resistance: Driving Alzheimer's as Type 3 Diabetes
Alzheimer's disease may be more than just amyloid plaques—emerging evidence points to brain insulin resistance as a core driver, earning it the label 'Type 3 diabetes.' A recent Polish study uncovers how impaired insulin signaling starves neurons of energy and accelerates toxic protein buildup. Discover the science and potential therapies like GLP-1 agonists that could change the game.
5 min read
Novo Nordisk's Extended Strategy with Weight Loss Medications Fuels Scientific Enthusiasm, Though Wall Street Remains Uneasy
Novo Nordisk has faced challenges with its stock and leadership due to the weight loss drug market. While scientists see potential in GLP-1 medications expanding beyond diabetes and obesity, investors are losing patience. Ongoing research highlights additional benefits like reducing cravings and aiding brain functions.
3 min read
How Eli Lilly's Mounjaro Is Transforming Obesity Treatment and the LLY Stock Narrative
Eli Lilly's Mounjaro, a groundbreaking GLP-1 agonist, is altering the landscape of obesity and diabetes management in the US. This article explores its market success, addresses key patient challenges, and delves into the investment implications for LLY stock, highlighting growth drivers and potential risks.
6 min read
I Tried Fiber-Loading for Two Weeks to Enhance Digestion and Energy – Nutritionists Validate It's Worth It
This article explores the potential benefits of increasing fiber intake, known as "fibermaxxing," for improved digestion and energy. A personal two-week experiment reveals the ease and impact of incorporating more fiber-rich foods into one's diet, supported by expert nutritionist recommendations.
6 min read
Research Suggests Diabetes Drug Ozempic May Offer Brain Protection
Recent research suggests that GLP-1 medications like Ozempic, typically used for diabetes and weight management, might also positively impact brain health. The study indicates a lower risk of epilepsy development in individuals with Type 2 diabetes using these drugs.
3 min read
Belly Fat Linked to Brain Aging, While Muscle Mass Keeps Brains Young
New research indicates a connection between body composition and brain aging. The study suggests that individuals with more muscle mass and less hidden belly fat tend to have younger-appearing brains, as observed through MRI scans.
4 min read
Gut-Brain Connection: How Gut Health Impacts Neurodegenerative Disease Risk
New research highlights the critical role of the gut-brain-immune axis in neurodegenerative diseases. Understanding this connection could unlock new approaches for prevention and treatment. Read on for key insights!
4 min read